NCT00669591 2017-04-21
A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
Peregrine Pharmaceuticals
Phase 2 Completed
Clinical Trials
3 trialsNCT01288261 2016-04-21
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
University of Arizona
Phase 1 Completed
NCT00669565 2011-03-24
Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer
Peregrine Pharmaceuticals
Phase 2 Completed